Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and thank you for joining Zephyr's first quarter 2026 financial results and corporate update conference call. Today's call is being recorded and will be available via the investor relations section of the company's website later today. The host for today's call is Nicole Oshner, Zephyr's vice president of investor relations and corporate communications. Thank you. And welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our first quarter 2026 financial results. I encourage you to read our financial results news release, which was distributed this afternoon and is available in the investor section of our website. Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties associated with ZEVR's business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties, and other important factors that may lead to actual results differing materially from projections made. and should be evaluated together with the risk factor section in our most recent quarterly report on Form 10-Q, our annual report on Form 10-K, and our filings with the SEC. I am pleased to welcome ZEVRA's management team members participating in today's call. Neal McFarling, SEVRA's President and Chief Executive Officer, Josh Schaefer, our Chief Commercial Officer, and Justin Renz, our Chief Financial Officer. Our Chief Medical Officer, Adrian Cortell, will also be available for today's question and answer session. Now, it's my pleasure to hand the call over to Neal. Thank you, Nicole...